echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > BeiGene released the latest data at the 2022 European Conference on Oncology, including the results of an oral report on the study of terelizumab for first-line unresectable hepatocellular carcinoma

    BeiGene released the latest data at the 2022 European Conference on Oncology, including the results of an oral report on the study of terelizumab for first-line unresectable hepatocellular carcinoma

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Tags

    cancer killer

    5 10 models

    chemotherapy drugs classification
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com